<code id='4A0754965C'></code><style id='4A0754965C'></style>
    • <acronym id='4A0754965C'></acronym>
      <center id='4A0754965C'><center id='4A0754965C'><tfoot id='4A0754965C'></tfoot></center><abbr id='4A0754965C'><dir id='4A0754965C'><tfoot id='4A0754965C'></tfoot><noframes id='4A0754965C'>

    • <optgroup id='4A0754965C'><strike id='4A0754965C'><sup id='4A0754965C'></sup></strike><code id='4A0754965C'></code></optgroup>
        1. <b id='4A0754965C'><label id='4A0754965C'><select id='4A0754965C'><dt id='4A0754965C'><span id='4A0754965C'></span></dt></select></label></b><u id='4A0754965C'></u>
          <i id='4A0754965C'><strike id='4A0754965C'><tt id='4A0754965C'><pre id='4A0754965C'></pre></tt></strike></i>

          hotspot

          hotspot

          author:fashion    Page View:96
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          A preacher's new calling: Diversifying neuroscience research
          A preacher's new calling: Diversifying neuroscience research

          TheauthorpreachingatUnionBaptistChurchinBaltimore.CourtesyEvelynJ.ChatmonWhenIwasthepastorofalargeBa

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Excited delirium, Elijah McClain, and emergency physicians

          Theterm“exciteddelirium”hasbeenusedforyearsbylawenforcementandotherfirstresponders,includinghealthca